Evidence map›Paper›PMID 26077244›Full record

ArticleBMC neuroscience2015

Targeted inhibition of the Shroom3-Rho kinase protein-protein interaction circumvents Nogo66 to promote axon outgrowth.

Heather M Dickson, Amanda Wilbur, Ashley A Reinke, Mathew A Young, Anne B Vojtek

Open access · goldAbstract read
In one paragraph

Article in BMC neuroscience, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.4field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Mapping Shroom3 expression across the adult mouse.Gene expression patterns : GEP · 2025
    Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Heather M DicksonDepartment of Biological Chemistry, University of Michigan Medical School, Ann Arbor, MI, USA. dicksonh@umich.edu.
Amanda WilburDepartment of Biological Chemistry, University of Michigan Medical School, Ann Arbor, MI, USA. amwilbur@umich.edu.
Ashley A ReinkeDepartment of Biological Chemistry, University of Michigan Medical School, Ann Arbor, MI, USA. aareinke6@gmail.com.
Mathew A YoungDepartment of Pharmacology, University of Michigan Medical School, Ann Arbor, MI, USA. youngmat@umich.edu.
Anne B VojtekDepartment of Biological Chemistry, University of Michigan Medical School, Ann Arbor, MI, USA. avojtek@umich.edu.
University of Michigan · US

Funding

XenograftP30CA046592 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Alexey I Nesvizhskii · 1988 to 2026
$178.2M
Michigan Institute for Clinical and Health Research (MCHR)UL1TR000433 · NCATS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MASHOUR, GEORGE ALEXANDER · 2012 to 2016
$49.9M
Regional Pilot And Feasibility Study Grants ProgramP30DK020572 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Mehboob A Hussain · 2013 to 2026
$24.3M
Cellular Biotechnology Training Program (CBTP)T32GM008353 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI SCHWENDEMAN, ANNA · 1991 to 2021
$9.3M
Cellular Biotechnology Training Program (CBTP) - Years 31-35T32GM145304 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Guizhi Zhu · 2022 to 2026
$2.6M
Identification of small molecules that can overcome CNS myelin inhibitionR21AG034264 · NIA · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI VOJTEK, ANNE B · 2010 to 2011
$337k
NCATS NIH HHS UL1 TR000433NCATS NIH HHS UL1TR000433NCI NIH HHS P30 CA046592NIA NIH HHS R21 AG034264NIA NIH HHS R21AG034264NIDDK NIH HHS P30 DK020572NIGMS NIH HHS T32 GM008353NIGMS NIH HHS T32 GM145304
6 · The paper itself

Abstract

backgroundInhibitory molecules in the adult central nervous system, including NogoA, impede neural repair by blocking axon outgrowth. The actin-myosin regulatory protein Shroom3 directly interacts with Rho kinase and conveys axon outgrowth inhibitory signals from Nogo66, a C-terminal inhibitory domain of NogoA. The purpose of this study was to identify small molecules that block the Shroom3-Rho kinase protein-protein interaction as a means to modulate NogoA signaling and, in the longer term, enhance axon outgrowth during neural repair.

resultsA high throughput screen for inhibitors of the Shroom3-Rho kinase protein-protein interaction identified CCG-17444 (Chem ID: 2816053). CCG-17444 inhibits the Shroom3-Rho kinase interaction in vitro with micromolar potency. This compound acts through an irreversible, covalent mechanism of action, targeting Shroom3 Cys1816 to inhibit the Shroom3-Rho kinase protein-protein interaction. Inhibition of the Shroom3-Rho kinase protein-protein interaction with CCG-17444 counteracts the inhibitory action of Nogo66 and enhances neurite outgrowth.

conclusionsThis study identifies a small molecule inhibitor of the Shroom3-Rho kinase protein-protein interaction that circumvents the inhibitory action of Nogo66 in neurons. Identification of a small molecule compound that blocks the Shroom3-Rho kinase protein-protein interaction provides a first step towards a potential new strategy for enhancing neural repair.

Indexed as

AnimalsAxonsCell EnlargementCell Line, TumorCells, CulturedCerebellumDose-Response Relationship, DrugEscherichia coliHigh-Throughput Screening AssaysMiceMicrofilament ProteinsMyelin ProteinsNogo ProteinsProtein Kinase InhibitorsPyrimidinonesQuinolonesCCG-17444Microfilament ProteinsMyelin ProteinsNogo ProteinsProtein Kinase InhibitorsPyrimidinonesQuinolonesRecombinant Proteinsrho-Associated KinasesRtn4 protein, mouseShrm protein, mouse

Identifiers

PMID26077244
PMCPMC4467669
OpenAlexW2119459001

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.